Oppenheimer analyst Christopher Glynn maintained a Perform rating for Generac Holdings (NYSE:GNRC) following the company's fourth-quarter earnings report. According to InvestingPro data, Generac is ...

Oppenheimer reiterated its Outperform rating and $115.00 price target for Gilead Sciences (NASDAQ:GILD) stock, following a strong fourth-quarter performance that surpassed consensus estimates. Gilead ...

In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

Analysts at Oppenheimer said in a research note on Tuesday that billionaire Elon Musk's recent bid for ChatGPT parent OpenAI ...

In the eyes of Tesla shareholders, Elon Musk hardly needed another distraction. OpenAI could turn out to be a costly one.

Elon Musk, the world’s richest person, saw his net worth drop below $400 billion for the first time in 2025 as Tesla Inc. shares slumped due to investor concerns regarding the electric vehicle (EV) ...

At its current pre-market price, Tesla's stock is down 33% since hitting a record high on Dec. 18, 2024, weeks after the ...

Retirement Systems of Alabama decreased its stake in Albemarle Co. (NYSE:ALB – Free Report) by 2.5% during the 4th quarter, ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports ...

More names of stars presenting the 97th Oscars on March 2 have been announced. Halle Berry, Penelope Cruz, Elle Fanning, ...

Zurn Elkay has filed a registration statement (including a base prospectus) on Form S-3 and a preliminary prospectus supplement with the Securities and Exchange Commission (the “SEC”) for the offering ...

BYD had previously offered self-driving technology to cars costing $30,000 and higher, but analysts noted that will now be offered on 21 models, including some under $10,000. Tesla's full self-driving ...